Cas:921939-00-6 2-[4-(chloromethyl)phenoxy]-6-methylpyrazine manufacturer & supplier

Chemical Name:2-[4-(chloromethyl)phenoxy]-6-methylpyrazine

CAS.NO:921939-00-6

Synonyms:2-[4-(chloromethyl)phenoxy]-6-methylpyrazine

Molecular Formula:C₁₂H₁₁ClN₂O

Molecular Weight:234.68200

HS Code:

Physical and Chemical Properties:

Melting point:41.5-44ºC

Boiling point:351.8ºC at 760 mmHg

Density:1.232g/cm3

Index of Refraction:1.581

PSA:35.01000

Exact Mass:234.05600

LogP:3.31610

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-[4-(chloromethyl)phenoxy]-6-methylpyrazine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-[4-(chloromethyl)phenoxy]-6-methylpyrazine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-[4-(chloromethyl)phenoxy]-6-methylpyrazine Use and application,2-[4-(chloromethyl)phenoxy]-6-methylpyrazine technical grade,usp/ep/jp grade.

Related News: At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs. 2-[4-(chloromethyl)phenoxy]-6-methylpyrazine manufacturer The Company��s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA. 2-[4-(chloromethyl)phenoxy]-6-methylpyrazine supplier Combining its core technological advantages such as ammonia oxidation, phosgenation, and fluorination, the company actively enters the field of fine and functional chemicals, and expands its focus to include polymer additives, replacement of phenolic polymer material monomers, and coating preservatives. 2-[4-(chloromethyl)phenoxy]-6-methylpyrazine vendor The Company��s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA. 2-[4-(chloromethyl)phenoxy]-6-methylpyrazine factory At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs.